BIO
Andrew
Fine
Senior Advisor in Division of Clinical Review in OGD
FDA
Commander Andrew Fine serves as Senior Advisor in FDA's Office of Generic Drugs, providing clinical and regulatory oversight. Previously a seven-year team leader supporting the Generic Drug Program. He holds a PharmD from University of Illinois, completed residency at Northwestern Memorial Hospital, is pharmacotherapy board certified, and earned a pharmacoepidemiology certificate from University of Pennsylvania.
